Monte Rosa Therapeutics, Inc. GLUE Collaboration Receivable Current
Collaboration Receivable Current at other companies
Other financials
Where this comes from
Reported directly by Monte Rosa Therapeutics, Inc. in its filing.
Tagged under the XBRL concept glue:CollaborationReceivableCurrent.
The official record: Monte Rosa Therapeutics, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Monte Rosa Therapeutics, Inc.'s collaboration receivable current.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Monte Rosa Therapeutics, Inc.'s collaboration receivable current?
- Monte Rosa Therapeutics, Inc. (GLUE) reported collaboration receivable current of $0 in Q1 2026.
- What does collaboration receivable current mean?
- This metric represents the portion of accounts receivable arising from research and development collaboration agreements that is expected to be collected within one year. It reflects the value of services performed or milestones achieved under partnership contracts for which payment has been earned but not yet received. Monitoring this balance provides insight into the timing of cash inflows from strategic partnerships and the company's ability to convert contractual obligations into liquid capital.